Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

Abstract Background In 1997, the Radiation Therapy Oncology Group (RTOG) put forward the recursive partitioning analysis classification for the prognosis of brain metastases (BMs), but this system does not take into account the epidermal growth factor receptor (EGFR) mutations. The aim of the study...

Full description

Bibliographic Details
Main Authors: Jing Wang, Zhiyan Liu, Qingsong Pang, Tian Zhang, Xi Chen, Puchun Er, Yuwen Wang, Ping Wang, Jun Wang
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
Brain metastasis
epidermal growth factor receptor mutation
Prognosis
Treatment
Online Access:http://link.springer.com/article/10.1186/s12885-020-07249-7

Internet

http://link.springer.com/article/10.1186/s12885-020-07249-7

Similar Items